Sign Up to like & get
recommendations!
0
Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.16082
Abstract: Background/Aim: The prognosis of recurring and metastatic head and neck squamous cell carcinoma (HNSCC) is poor. Although immune checkpoint inhibitors have expanded the treatment options for HNSCC, the response rates are low. Alternatively, cancer vaccines…
read more here.
Keywords:
cancer antigens;
head neck;
expression;
neck squamous ... See more keywords